Unknown

Dataset Information

0

Critical role of cyclin B1/Cdc2 up-regulation in the induction of mitotic prometaphase arrest in human breast cancer cells treated with 2-methoxyestradiol.


ABSTRACT: Earlier studies showed that 2-methoxyestradiol (2ME(2)), an endogenous nonpolar metabolite of estradiol-17?, is a strong inducer of G(2)/M cell cycle arrest (based on analysis of cellular DNA content) in human cancer cell lines. The present study sought to investigate the molecular mechanism underlying 2ME(2)-induced cell cycle arrest. We found that 2ME(2) can selectively induce mitotic prometaphase arrest, but not G(2) phase arrest, in cultured MDA-MB-435s and MCF-7 human breast cancer cells. During the induction of prometaphase arrest, there is a time-dependent initial up-regulation of cyclin B1 and Cdc2 proteins, occurring around 12-24h. The strong initial up-regulation of cyclin B1 and Cdc2 matches in timing the 2ME(2)-induced prometaphase arrest. The 2ME(2)-induced prometaphase arrest is abrogated by selective knockdown of cyclin B1 and Cdc2, or by pre-treatment of cells with roscovitine, an inhibitor of cyclin-dependent kinases, or by co-treatment of cells with cycloheximide, a protein synthesis inhibitor that was found to suppress the early up-regulation of cyclin B1 and Cdc2. In addition, we provided evidence showing that MAD2 and JNK1 are important upstream mediators of 2ME(2)-induced up-regulation of cyclin B1 and Cdc2 as well as the subsequent induction of mitotic prometaphase arrest. In conclusion, treatment of human cancer cells with 2ME(2) causes up-regulation of cyclin B1 and Cdc2, which then mediate the induction of mitotic prometaphase arrest.

PROVIDER: S-EPMC3777406 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

2011-01-01 | S-EPMC3168870 | BioStudies
1000-01-01 | S-EPMC1190358 | BioStudies
2016-01-01 | S-EPMC5037805 | BioStudies
1000-01-01 | S-EPMC2906566 | BioStudies
| S-EPMC5938023 | BioStudies
2003-01-01 | S-EPMC206994 | BioStudies
2017-01-01 | S-EPMC5441038 | BioStudies
1000-01-01 | S-EPMC5650293 | BioStudies
2019-01-01 | S-EPMC6416240 | BioStudies
1000-01-01 | S-EPMC2910263 | BioStudies